A novel transgenic mouse model of CBS-deficient homocystinuria does not incur hepatic steatosis or fibrosis and exhibits a hypercoagulative phenotype that is ameliorated by betaine treatment

Abstract
No abstract available
Funding Information
  • Jerome Lejeune Foundation
  • NICHD (P30 HD04024-39, HD17449)
  • Special Products U.K.
  • William R. Hummel Homocystinuria Research Fund
  • Denver Children's Hospital (6703)
  • NIH (HL65217)
  • Wellcome Trust International Senior Fellowship in Biomedical Science in Central Europe (070255/Z/03/Z)
  • Research Project from the Ministry of Education, Youth and Sports of the Czech Republic (MSM0021620806)

This publication has 30 references indexed in Scilit: